ENO2 and benign prostatic hyperplasia: By contrast, other NE markers (NSE and adrenomedullin) were expressed uniformly across normal peritumoral and tumoral regions, and across PCa and benign prostate hyperplasia patients, respectively, which suggests that the prostate may contain several different NE cell populations (10).